Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 24. August 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9046  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180906  
   
circ-ITCH suppresses prostate cancer cell proliferation, migration and invasion in-vitro through the miR-106b-5p/SETD2 axis.
Pak J Pharm Sci
Jiang J, Wei J, Chen F, Li Y, Ba L, Pan B.
PMID: 42633546 [PubMed - indexed for MEDLINE]


Real-World Comparison of Abiraterone Acetate Versus Docetaxel in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Cohort Study From Vietnam.
Cancer Control
Nguyen H, Nguyen H, Nguyen HX, Truong M, Ngo T.
PMID: 42633534 [PubMed - indexed for MEDLINE]


Mitochondrial convergence of ferroptosis and cuproptosis in castration-resistant prostate cancer: From metabolic vulnerabilities to therapeutic targeting.
BBA Adv
Wang CL, Lv JT, Liu SJ, Zhang YY, Wang SL, Song SQ.
PMID: 42633322 [PubMed]


Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.
Urol Oncol
Teixeira EG, Torres LAF, Defante MLR, de Azevedo FM, Souza VC.
PMID: 42632294 [PubMed - as supplied by publisher]


A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis.
Urol Oncol
Shinohara M, Narita T, Hamaya T, Ichiyama T, Fujita N, Okamoto T, Yamamoto H, Ohyama C, Hatakeyama S.
PMID: 42632293 [PubMed - as supplied by publisher]


miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression.
Urol Oncol
Wang L, Yang H, Wang J.
PMID: 42632292 [PubMed - as supplied by publisher]


Clinical characteristics, treatment patterns, and survival outcomes in ductal prostate cancer: a multicenter retrospective analysis.
World J Urol
Handke A, Paffenholz P, Schlack K, Seifert KE, Linxweiler J, Mink J, Flockerzi F, Nestler T, Wenzel M, Siech C, Darr C, Grünwald V, Roghmann F, Tully KH.
PMID: 42631874 [PubMed - indexed for MEDLINE]


The Intersection of Religiosity, Perceived Discrimination, and Psychological Well-Being in a Racially and Ethnically Diverse Sample of Male Cancer Survivors.
Cancer Control
Murphy A, Fletcher-Duncan A, Cherell CD, Li X, Fan W, Jacobs KL, Denis J, Lezama C, Bethune B, Hu B, Gonzalez BD, Green BL.
PMID: 42631521 [PubMed - indexed for MEDLINE]


Optimizing Sequential Decision Rules for Prostate Cancer Biopsy Management: A Multi-Objective Statistical Framework.
J Am Stat Assoc
Qiu J, Zhao YQ, Wei J, Chinnaiyan AM, Tosoian J, Zheng Y.
PMID: 42631260 [PubMed]


Mitochondrial Dysfunction in Renal Cell Carcinoma: A Comprehensive Review of Pathogenic Mechanisms and Emerging Therapeutic Opportunities.
Oncol Res
Wang Y, Liu J, Xu Q, Ma Z.
PMID: 42630702 [PubMed - indexed for MEDLINE]


Combining PSA density and imaging data with transcript markers from urinary cells to improve prediction of prostate cancer reclassification in patients on active surveillance.
BJUI Compass
Borkowetz A, Gräfe S, Kwe J, Fuessel S, Thomas C, Erdmann K.
PMID: 42630620 [PubMed]


Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.
Ther Adv Med Oncol
Bimbatti D, Nasso C, Aspden D, Buti S, Antonj L, Signori A, Verzoni E, Lolli C, Di Napoli M, Fanelli M, De Lucia M, Masini C, Roviello G, Arduini D, Filippi R, Mennitto A, Sorarù M, Bozza G, Formisano L, Messina C, Bonomi L, Guida A, Fantinel E, Scagliarini S, Vitale MG, Chiellino S, Maiorano BA, Deppieri FM, Zucali PA, Cavo A, Caserta C, La Russa F, Conteduca V, Maines F, Zai S, Pierantoni F, Icardi M, Rescigno P, Di Costanzo F, Banna GL, Rebuzzi SE.
PMID: 42630506 [PubMed]


Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival.
Am J Transl Res
Jiang S, Du C, Qu L, Liu L, Ren B, Luo W.
PMID: 42630365 [PubMed]


The Local Effects of Systemic Therapies in Urological Oncology: A Systematic Review.
Cancer Med
Nordheimer S, Gofrit ON.
PMID: 42630020 [PubMed - indexed for MEDLINE]


Prognostic and immunological value of LINC01615-related genes in kidney clear cell carcinoma: Integrated bioinformatics analysis and expression validation.
Medicine (Baltimore)
Guo S, Xu S, Song P, Fu J, Wang S, Xie W, Wang Y.
PMID: 42629666 [PubMed - indexed for MEDLINE]


Re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.
Eur Urol Oncol
Di Bello F, Gallioli A, Palou J, Breda A.
PMID: 42629309 [PubMed - as supplied by publisher]


Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan.
Eur Urol Focus
Sciarra A, Casale P, Bevilacqua G, Basile G, Santarelli V, Buffi NM, Lazzeri M, Lunghezzani G, Lucciola S, Messina E, Laschena L, Dehghanpour A, Di Pierro GB, Franco G, Del Giudice F, Gentilucci A, Dipinto P, Corvino R, Salciccia S, Magliocca FM, Panebianco V.
PMID: 42629306 [PubMed - as supplied by publisher]


No Evidence of Post-Finasteride Syndrome in 267,983 person-years follow-up in the Prostate Cancer Prevention Trial.
Urology
Till C, Tangen CM, Goodman P, Unger JM, Thompson IM Jr.
PMID: 42628582 [PubMed - as supplied by publisher]


Age at Diagnosis and Postoperative Outcomes Among Men Treated for Prostate Cancer in the U.S. Military Health System.
Clin Genitourin Cancer
Oroho MR, Dide-Agossou C, Kern SQ, Almeida AA, Darmon S, Shriver CD, Zhu K, Eaglehouse YL.
PMID: 42628214 [PubMed - as supplied by publisher]


APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
JCO Precis Oncol
Shi X, Shetty AC, Wang J, Song Y, Sutera PA, Deek MP, Patel KR, Madan RA, Tang C, Proudfoot J, Davicioni E, Hussain A, Nguyen P, Sweeney C, Boytim E, Lacuna KP, Ryan CJ, Antonarakis ES, Tran PT, Hwang J.
PMID: 42628007 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 180906    Seite 1 von 9046  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1